{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:38:00Z","timestamp":1794649080049,"version":"4.9.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,22]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Myelin oligodendrocyte glycoprotein antibody (MOGA) associated diseases are inflammatory immune-mediated demyelinating disorders with relapse potential involving the central nervous system. Multiple unusual clinical manifestations of those disorders were reported, making treatment decisions difficult.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>A healthy 12-year-old obese boy presented with headache and bilateral asymmetric papilledema. The patient had a negative medical history. His neurological and general examinations were unremarkable, his initial magnetic resonance imaging showed elevated intracranial pressure (ICP) only. A lumbar puncture revealed increased opening pressure and pleocytosis. The MOGA titer was 1:320. He needed acetazolamide and steroid therapy. After 2 months of medication, weight loss, exercise, the patient symptoms significantly improved, papilledema resolved, and visual function improved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>MOGA-associated disorders have a variety of clinical features, so a high index of suspicion is required for their diagnosis. Papilledema and an elevated ICP are 2 of the chameleons of MOGA-associated disorders. MOGA test may be useful in patients with elevated ICP and inflammatory cerebrospinal fluid profiles. An investigation of the possible association between those disorders and high ICP is warranted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032986","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T12:00:49Z","timestamp":1677240049000},"page":"e32986","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Pediatric myelin oligodendrocyte glycoprotein antibody associated disease\u2014Asymmetric papilledema and elevated ICP are two of the chameleons: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Youssef","family":"Alqahtani","sequence":"first","affiliation":[{"name":"Department of Child Health, College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Oshi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Neurology Division, Alhada Armed Forces Hospital, Taif, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8535-3838","authenticated-orcid":false,"given":"Naglaa M.","family":"Kamal","sequence":"additional","affiliation":[{"name":"Pediatrics and Pediatric Hepatology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Aljabri","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Neurology Division, Alhada Armed Forces Hospital, Taif, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Abosabie","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Julius-Maximilians-Universit\u00e4t W\u00fcrzburg, Bavaria, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Elhaj","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Neurology Division, Alhada Armed Forces Hospital, Taif, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A","family":"Abosabie","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fneur.2018.00217","article-title":"MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder.","volume":"9","author":"Dos Passos","year":"2018","journal-title":"Front Neurol"},{"key":"R2-20250805","doi-asserted-by":"crossref","first-page":"2329048X221079093","DOI":"10.1177\/2329048X221079093","article-title":"Refractory MOG-associated demyelinating disease in a pediatric patient.","volume":"9","author":"Kroenke","year":"2022","journal-title":"Child Neurol Open"},{"key":"R3-20250805","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11910-019-1014-z","article-title":"Clinical characteristics and treatment of MOG-IgG-associated optic neuritis.","volume":"19","author":"Tajfirouz","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R4-20250805","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","article-title":"Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.","volume":"15","author":"Ramanathan","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R5-20250805","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes.","volume":"77","author":"Waters","year":"2020","journal-title":"JAMA Neurol"},{"issue":"16 Suppl 2","key":"R6-20250805","first-page":"S7","article-title":"Consensus definitions proposed for pediatric multiple sclerosis and related disorders.","volume":"68","author":"Krupp","year":"2007","journal-title":"Neurology"},{"key":"R7-20250805","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis.","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy.","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R10-20250805","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/WNO.0000000000000205","article-title":"Asymmetric papilledema in idiopathic intracranial hypertension.","volume":"35","author":"Bidot","year":"2015","journal-title":"J Neuroophthalmol"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study.","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol"},{"key":"R13-20250805","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/dmcn.13703","article-title":"Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.","volume":"60","author":"Duignan","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"104319","DOI":"10.1016\/j.neuint.2018.10.016","article-title":"Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.","volume":"130","author":"Akaishi","year":"2019","journal-title":"Neurochem Int"},{"key":"R15-20250805","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin Oligodendrocyte Glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome.","volume":"195","author":"Chen","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R16-20250805","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00415-018-8956-y","article-title":"Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation.","volume":"265","author":"Lotan","year":"2018","journal-title":"J Neurol"},{"key":"R17-20250805","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.msard.2018.10.003","article-title":"Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations.","volume":"27","author":"Narayan","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"R18-20250805","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1352458515587751","article-title":"Clinical and MRI phenotype of children with MOG antibodies.","volume":"22","author":"Fernandez-Carbonell","year":"2016","journal-title":"Mult Scler"},{"key":"R19-20250805","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pediatrneurol.2015.01.002","article-title":"Elevated cerebrospinal fluid opening pressure in a pediatric demyelinating disease cohort.","volume":"52","author":"Narula","year":"2015","journal-title":"Pediatr Neurol"},{"key":"R20-20250805","doi-asserted-by":"crossref","first-page":"102638","DOI":"10.1016\/j.msard.2020.102638","article-title":"Variability of cerebrospinal fluid findings by attack phenotype in myelin oligodendrocyte glycoprotein-IgG-associated disorder.","volume":"47","author":"Sechi","year":"2021","journal-title":"Mult Scler Relat Disord"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T20:10:50Z","timestamp":1754424650000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032986","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,22]]}}}